Cargando…
The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys
The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/ https://www.ncbi.nlm.nih.gov/pubmed/26306721 http://dx.doi.org/10.1038/srep13546 |
_version_ | 1782387350950641664 |
---|---|
author | Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan |
author_facet | Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan |
author_sort | Wang, Wenying |
collection | PubMed |
description | The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings. |
format | Online Article Text |
id | pubmed-4549711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-45497112015-09-04 The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan Sci Rep Article The epidemiological characteristics of benign prostate hyperplasia (BPH) in mainland China are not completely understood. We performed this meta-analysis to assess the prevalence of BPH from 1989 through 2014. A total of 14 articles and 19 datasets were included. The pooled overall prevalence of BPH among men aged 40 years and older was 36.6% [95% CI, 32.3–44.8]. The occurrence rate of BPH in the age groups 40–49 years, 50–59 years, 60–69 years, 70–79 years and 80 years and older was 2.9%, 29.0%, 44.7%, 58.1% and 69.2%, respectively. The pooled occurrence rate of BPH was 41.5% [95% CI, 34.5–48.4] in urban areas and 38.6% [95% CI, 22.7–54.6] in rural areas; this difference in prevalence was not statistically significant [OR, 1.51; 95% CI, 0.97–2.36]. BPH is highly prevalent in mainland China, and its prevalence increased with age. The trend in the prevalence of BPH in mainland China was not steady; the prevalence map based on a geographic information system (GIS) showed an unequal geographic distribution. High-quality surveys on BPH with a larger sample size are needed throughout mainland China to confirm these findings. Nature Publishing Group 2015-08-26 /pmc/articles/PMC4549711/ /pubmed/26306721 http://dx.doi.org/10.1038/srep13546 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Wang, Wenying Guo, Yuwen Zhang, Daoxin Tian, Ye Zhang, Xiaonan The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title_full | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title_fullStr | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title_full_unstemmed | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title_short | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys |
title_sort | prevalence of benign prostatic hyperplasia in mainland china: evidence from epidemiological surveys |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549711/ https://www.ncbi.nlm.nih.gov/pubmed/26306721 http://dx.doi.org/10.1038/srep13546 |
work_keys_str_mv | AT wangwenying theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT guoyuwen theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT zhangdaoxin theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT tianye theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT zhangxiaonan theprevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT wangwenying prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT guoyuwen prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT zhangdaoxin prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT tianye prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys AT zhangxiaonan prevalenceofbenignprostatichyperplasiainmainlandchinaevidencefromepidemiologicalsurveys |